Octofeb Pharma Private Limited - Company Profile

It is a pharma private limited company based in Karnal, Haryana, India, established in 2017.
2017 Karnal, Haryana, India Active
Last Updated:
Access Report
About Octofeb Pharma Private Limited

Octofeb Pharma Private Limited, a active private limited company, was established on 04 May 2017 in Karnal, Haryana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24304HR2017PTC068918. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Anshul Kumar (Director), Gaurav Dawar (Director). It holds ₹3.43 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor, Plot No. 208-B Sector 3, Hsiidc Industrial Estate, Karnal, Haryana, 132001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304HR2017PTC068918

  • Registration Number

    068918

  • Incorporation Date

    04 May 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.43 M
  • Revenue Growth **** 38.47%
  • Profit Growth **** -50.17%
  • Ebitda **** 52.02%
  • Net Worth -40.43%
  • Total Assets -7.48%
Company report

Octofeb Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Octofeb Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Octofeb Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Anshul Kumar Director 04 May 2017 Current
Gaurav Dawar Director 04 May 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Octofeb Pharma.

Octofeb Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.47% increase. The company also saw a substantial fall in profitability, with a 50.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.43%.

Octofeb Pharma revenue growth over time
Octofeb Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 38.47%
*******
*******
*******
*******
Revenue from Operations
*******
 38.47%
*******
*******
*******
*******
Total Assets
*******
 -7.48%
*******
*******
*******
*******
Profit or Loss
*******
 -50.17%
*******
*******
*******
*******
Net Worth
*******
 -40.43%
*******
*******
*******
*******
EBITDA
*******
 52.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Octofeb Pharma?

In 2020, Octofeb Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,425,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.34 Cr
Latest Charge Details
Date Lender Amount Status
18 Nov 2021 Canara Bank ₹0.43 M Open
17 Dec 2019 Canara Bank ₹3.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Octofeb Pharma?

Unlock and access historical data on people associated with Octofeb Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Octofeb Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Octofeb Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Octofeb Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Octofeb Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Octofeb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank of Rs. 3.00 M registered on 17 Dec 2019 with Charge ID 100316836 was modified on 22 Jan 2025. was completed.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 0.43 M with Charge ID 100509006 was registered on 18 Nov 2021. was completed.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 3.00 M with Charge ID 100316836 was registered on 17 Dec 2019. was documented.

  • Director Appointment

    Anshul Kumar was appointed as a Director was appointed as a Director on 04 May 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Octofeb Pharma Private Limited?

The CIN of Octofeb Pharma Private Limited is U24304HR2017PTC068918.

Where is Octofeb Pharma Private Limited headquartered?

Octofeb Pharma Private Limited is headquartered at Ground Floor, Plot No. 208-B Sector 3, Hsiidc Industrial Estate, Karnal, Haryana, 132001.

When was Octofeb Pharma Private Limited incorporated?

Octofeb Pharma Private Limited was incorporated on 04 May 2017.

Who are the current directors of Octofeb Pharma Private Limited?

The current directors of Octofeb Pharma Private Limited are

What is the primary industry of Octofeb Pharma Private Limited?

The primary industry of Octofeb Pharma Private Limited is Manufacturing.

Is Octofeb Pharma Private Limited a listed company?

Octofeb Pharma Private Limited is unlisted.

What is the capital structure of Octofeb Pharma Private Limited?

The authorized capital of Octofeb Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Octofeb Pharma Private Limited?

The compliance status of Octofeb Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available